# EDGAR Filing Document

**Accession Number:** 0000846475
**File Stem:** 0000000000-25-006977
**Filing Date:** 2025-7
**Character Count:** 3147
**Document Hash:** 50f9ebd0b6059daaa435749d5bcddce6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-006977.hdr.sgml**: 20250915

**ACCESSION NUMBER**: 0000000000-25-006977

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250702

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ZYNEX INC
- **CENTRAL INDEX KEY:** 0000846475
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 870403828
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 001-38804

**BUSINESS ADDRESS:**
- **STREET 1:** 9655 MAROON CIRCLE
- **CITY:** ENGLEWOOD
- **STATE:** CO
- **ZIP:** 80112
- **BUSINESS PHONE:** (800)-495-6670

**MAIL ADDRESS:**
- **STREET 1:** 9655 MAROON CIRCLE
- **CITY:** ENGLEWOOD
- **STATE:** CO
- **ZIP:** 80112

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ZYNEX MEDICAL HOLDINGS INC
- **DATE OF NAME CHANGE:** 20050812

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ZYNEX MEDICAL HOLDINGS   INC
- **DATE OF NAME CHANGE:** 20040120

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** FOX RIVER HOLDINGS  INC
- **DATE OF NAME CHANGE:** 20031126
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001558370-25-002717

## Text-Extract

```

                                                              July 2, 2025

Daniel Moorhead
Chief Financial Officer
ZYNEX INC
9655 Maroon Circle
Englewood, CO 80112

        Re: ZYNEX INC
            Correspondence filed June 5, 2025
            File No. 001-38804
Dear Daniel Moorhead:

        We have reviewed your June 5, 2025 response to our May 21, 2025 comment
letter
and have the following comment. Please respond to this letter within ten
business days by
providing the requested information or advise us as soon as possible when you
will respond.
If you do not believe the comment applies to your facts and circumstances,
please tell us why
in your response. After reviewing your response to this letter, we may have
additional
comments.

Correspondence filed June 5, 2025
Recent Events, page 7

1.     We have read your response to prior comment 3. Please provide a loss
contingency
       disclosure in the financial statement footnotes that clearly states
whether a liability has
       been accrued for the potential repayment of prior Tricare cash
collections. See also
       ASC 450-20-50.
       Please contact Al Pavot at 202-551-3738 or Terence O'Brien at
202-551-3355 if you
have questions regarding comments on the financial statements and related
matters. Please
contact Juan Grana at 202-551-6034 or Katherine Bagley at 202-551-2545 with any
other
questions.

                                                              Sincerely,

                                                              Division of
Corporation Finance
                                                              Office of
Industrial Applications and
                                                              Services

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._